NASDAQ:GHRS

GH Research PLC Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$11.19

-0.760 (-6.36%)

At Close: May 02, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for GHRS

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	12.52	11.92 %
		R2	12.14	8.50 %
		R1	11.91	6.39 %
Current price:			11.19
	Support	S1	11.14	-0.435 %
		S2	10.91	-2.54 %
		S3	10.52	-5.96 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	11.95	6.79 %
		R2	11.72	4.74 %
		R1	11.30	0.98 %
Current price			11.19
	Support	S1	11.00	-1.70%
		S2	9.25	-17.34%
		S3	8.49	-24.13%

GHRS Predictions History

2 weeks ago
npithia predicted that GHRS for Apr. 15th is going

Rank:

About GH Research PLC

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1... GHRS Profile

Golden Star

Ticker	Date	Change	Price
BSCQ	Apr 30	0.393%	$19.09
EQC	Apr 30	1.76%	$18.72
HRB	Apr 30	1.69%	$47.23
REG	Apr 30	1.35%	$59.22
INGR	Apr 30	0.576%	$114.59
BSJP	Apr 29	0.175%	$22.91
LYG	Apr 29	0.781%	$2.56
ORA	Apr 29	3.46%	$64.48
DHT	Apr 24	4.34%	$11.28
LPLA	Apr 19	2.62%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In